2024
Postrelease Risk of Overdose and All-Cause Death Among Persons Released From Jail or Prison: Minnesota, March 2020-December 2021.
Hill K, Bodurtha P, Winkelman T, Howell B. Postrelease Risk of Overdose and All-Cause Death Among Persons Released From Jail or Prison: Minnesota, March 2020-December 2021. American Journal Of Public Health 2024, 114: 913-922. PMID: 39024534, PMCID: PMC11306622, DOI: 10.2105/ajph.2024.307723.Peer-Reviewed Original ResearchConceptsOverdose deathsPrison exposureJailPrisonRisk of overdoseRates of overdose deathsOverdose death ratesOpioid use disorderGeneral populationDeath recordsDrug overdosePeopleStandardized mortality ratioPersonsIncarcerationUse disorderPostreleaseMortality ratioDeath rateRisk of deathRetrospective cohort studyMortality riskCohort studyMinnesotaOverdoseBuprenorphine-naloxone vs. extended-release naltrexone for opioid use disorder in individuals with and without criminal legal involvement: A secondary analysis of the X:BOT randomized controlled trial
Balter D, Puglisi L, Dziura J, Fiellin D, Howell B. Buprenorphine-naloxone vs. extended-release naltrexone for opioid use disorder in individuals with and without criminal legal involvement: A secondary analysis of the X:BOT randomized controlled trial. Journal Of Substance Use And Addiction Treatment 2024, 164: 209438. PMID: 38857827, PMCID: PMC11300157, DOI: 10.1016/j.josat.2024.209438.Peer-Reviewed Original ResearchXR-NTXBuprenorphine-naloxoneOpioid use disorderCriminal legal involvementUse disorderHazard of overdoseLifetime incarcerationLegal involvementOpioid use disorder treatment outcomesPer-protocol analysisExtended-release naltrexoneMOUD effectivenessTreatment outcomesEffects of medicationHazard of relapseSecondary analysisIntention-to-treat analysisIntention-to-treatRandomized controlled trialsEffects of MOUDRelapseControlled trialsDisordersOpioidPotential effect modifiersAccessibility of Opioid Treatment Programs Based on Conventional vs Perceived Travel Time Measures
Kim J, Lee J, Thornhill T, Dennett J, Lu H, Howell B, Grau L, Fiellin D, Heimer R, Gonsalves G. Accessibility of Opioid Treatment Programs Based on Conventional vs Perceived Travel Time Measures. JAMA Network Open 2024, 7: e240209. PMID: 38376839, PMCID: PMC10879949, DOI: 10.1001/jamanetworkopen.2024.0209.Peer-Reviewed Original ResearchConceptsTransit travel timeAccessibility metricsTravel timeTravel componentsAccessibility scoresTransportation burdenTravel burdenOut-of-vehicleComponents of travelConventional accessibility measuresSpatial regression modelsTravel time measurementsPublic transitTransit schedulesAccessibility measuresDeparture timeTravel time analysisTrip durationTravelOperating hoursTime analysisCross-sectional studyOpioid use disorderPolicy recommendationsDecision-making
2023
Treatment setting among individuals with opioid use and criminal legal involvement, housing instability, or Medicaid insurance, 2015-2021
Shearer R, Howell B, Khatri U, Winkelman T. Treatment setting among individuals with opioid use and criminal legal involvement, housing instability, or Medicaid insurance, 2015-2021. Drug And Alcohol Dependence Reports 2023, 8: 100179. PMID: 37502021, PMCID: PMC10368753, DOI: 10.1016/j.dadr.2023.100179.Peer-Reviewed Original ResearchMedicaid insuranceTreatment settingsDoctor's officeReceipt of MOUDHousing instabilityOpioid use disorderMultivariable logistic regressionCross-sectional studyMental health facilitiesLower ratesMOUD useOpioid useHealth facilitiesProportion of individualsMOUDUse disordersMultiple treatment settingsLogistic regressionLegal involvementHigher likelihoodTreatmentRole TreatmentSimilar ratesLow incomeVariety of settings
2021
Changes In Health Services Use After Receipt Of Medications For Opioid Use Disorder In A Statewide Correctional System
Howell BA, Martin RA, Lebeau R, Truong AQ, Wang EA, Rich JD, Clarke JG. Changes In Health Services Use After Receipt Of Medications For Opioid Use Disorder In A Statewide Correctional System. Health Affairs 2021, 40: 1304-1311. PMID: 34339247, PMCID: PMC9036835, DOI: 10.1377/hlthaff.2020.02156.Peer-Reviewed Original ResearchConceptsOpioid use disorderReceipt of medicationHealth care useHealth service useCare useService useUse disordersTotal health care costsEmergency department visitsCorrectional settingsOpioid overdose mortalityEvidence-based treatmentsHealth care costsHealth care servicesRhode Island DepartmentUnified jailDepartment visitsPharmacy claimsInpatient admissionsMedicationsOutpatient servicesOverdose mortalityCare costsCare servicesAddiction treatmentThe Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN-PATHS): A hybrid type-1 effectiveness trial of enhanced primary care to improve opioid use disorder treatment outcomes following release from jail
Howell BA, Puglisi L, Clark K, Albizu-Garcia C, Ashkin E, Booth T, Brinkley-Rubinstein L, Fiellin DA, Fox AD, Maurer KF, Lin HJ, McCollister K, Murphy S, Morse DS, Shavit S, Wang K, Winkelman T, Wang EA. The Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN-PATHS): A hybrid type-1 effectiveness trial of enhanced primary care to improve opioid use disorder treatment outcomes following release from jail. Journal Of Substance Use And Addiction Treatment 2021, 128: 108315. PMID: 33583610, PMCID: PMC8319218, DOI: 10.1016/j.jsat.2021.108315.Peer-Reviewed Original ResearchConceptsTransitions Clinic NetworkOpioid use disorderPrimary careTreatment cascadeClinic networkOpioid Use Disorder Treatment OutcomesMedical needData Safety Monitoring BoardStandard primary careCommunity health centersCommunity health workersPrimary care teamsSafety monitoring boardCause of deathDisorder treatment outcomesPatient's medical needsHistory of incarcerationPolicy-level barriersOUD treatmentCare teamEffectiveness trialHealth centersTreatment outcomesCommon causeOpioid overdose